SECsense Logo

Nuvectis Pharma Inc. 8-K Filing Report - February 2025 Insights

$NVCT
Form 8-K
Filed on: 2025-02-25
Source
Nuvectis Pharma Inc. 8-K Filing Report - February 2025 Insights

Here is the key information extracted from the financial report section provided:

  1. Entity Information:
  • Company Name: Nuvectis Pharma, Inc.
  • CIK: 0001875558
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-41264
  • Tax ID: 86-2405608
  • Address: 1 Bridge Plaza Suite 275, Fort Lee, NJ 07024
  • Phone Number: 201-614-3150
  1. Stock Information:
  • Common Stock Ticker Symbol: NVCT
  • Exchange: NASDAQ
  1. Filing Details:
  • Form Type: 8-K
  • Filing Date: February 25, 2025
  1. Financial Context:
  • Report Date: The report covers information as of February 25, 2025.
  • Currency: All amounts are reported in USD (United States Dollar).
  • Unit of Measurement: The report includes figures in shares.
  1. Link to Schema: The filing references an XML schema (nvct-20250225.xsd) for structure and validation.

Insights:

  • The company appears to be publicly traded on NASDAQ, indicating it is subject to SEC regulations and reporting requirements.
  • The specific mention of the 8-K form suggests that this filing may contain significant events or changes that occurred up to the filing date, which could impact investors' decisions.
  • The report is structured in XBRL format, indicating data is intended for digital consumption and analysis, which is beneficial for transparency and accessibility for investors and analysts.

This information is critical for stakeholders to understand the current status and operational context of Nuvectis Pharma, Inc. as of the specified date.